Page last updated: 2024-11-12

m 35

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

galanin-(1-13)-bradykinin-(2-9)-amide: a high-affinity galanin receptor antagonist [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID16131186
MeSH IDM0200079

Synonyms (8)

Synonym
galanin-(1-13)-bradykinin-(2-9)-amide
m 35
l-argininamide, glycyl-l-tryptophyl-l-threonyl-l-leucyl-l-asparaginyl-l-seryl-l-alanylglycyl-l-tyrosyl-l-leucyl-l-leucylglycyl-l-prolyl-l-prolylglycyl-l-phenylalanyl-l-seryl-l-prolyl-l-phenylalanyl-
m-35
NCGC00167245-01
galanin(1-13)-bradykinin(2-9)amide
mfcd00237055
DTXSID20162199
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (3)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Galanin receptor type 2Homo sapiens (human)Ki0.00180.00110.00150.0018AID459287
Galanin receptor type 1Homo sapiens (human)Ki0.00000.00000.00000.0001AID459286
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Galanin receptor type 2Homo sapiens (human)Kd0.00200.00100.00270.0050AID413941
Galanin receptor type 3Homo sapiens (human)Kd0.01500.01500.12330.3150AID413942
Galanin receptor type 1Homo sapiens (human)Kd0.00010.00010.00120.0032AID413940
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (19)

Processvia Protein(s)Taxonomy
muscle contractionGalanin receptor type 2Homo sapiens (human)
cell surface receptor signaling pathwayGalanin receptor type 2Homo sapiens (human)
adenylate cyclase-activating G protein-coupled receptor signaling pathwayGalanin receptor type 2Homo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathwayGalanin receptor type 2Homo sapiens (human)
positive regulation of cytosolic calcium ion concentrationGalanin receptor type 2Homo sapiens (human)
learning or memoryGalanin receptor type 2Homo sapiens (human)
feeding behaviorGalanin receptor type 2Homo sapiens (human)
neuron projection developmentGalanin receptor type 2Homo sapiens (human)
inositol phosphate metabolic processGalanin receptor type 2Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIGalanin receptor type 2Homo sapiens (human)
phosphatidylinositol metabolic processGalanin receptor type 2Homo sapiens (human)
galanin-activated signaling pathwayGalanin receptor type 2Homo sapiens (human)
positive regulation of large conductance calcium-activated potassium channel activityGalanin receptor type 2Homo sapiens (human)
adenylate cyclase-modulating G protein-coupled receptor signaling pathwayGalanin receptor type 2Homo sapiens (human)
neuropeptide signaling pathwayGalanin receptor type 2Homo sapiens (human)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messengerGalanin receptor type 3Homo sapiens (human)
chemical synaptic transmissionGalanin receptor type 3Homo sapiens (human)
learning or memoryGalanin receptor type 3Homo sapiens (human)
feeding behaviorGalanin receptor type 3Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIGalanin receptor type 3Homo sapiens (human)
galanin-activated signaling pathwayGalanin receptor type 3Homo sapiens (human)
neuropeptide signaling pathwayGalanin receptor type 3Homo sapiens (human)
adenylate cyclase-modulating G protein-coupled receptor signaling pathwayGalanin receptor type 3Homo sapiens (human)
adenylate cyclase-activating G protein-coupled receptor signaling pathwayGalanin receptor type 1Homo sapiens (human)
negative regulation of adenylate cyclase activityGalanin receptor type 1Homo sapiens (human)
positive regulation of cytosolic calcium ion concentrationGalanin receptor type 1Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIGalanin receptor type 1Homo sapiens (human)
positive regulation of cortisol secretionGalanin receptor type 1Homo sapiens (human)
neuropeptide signaling pathwayGalanin receptor type 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (5)

Processvia Protein(s)Taxonomy
galanin receptor activityGalanin receptor type 2Homo sapiens (human)
protein bindingGalanin receptor type 2Homo sapiens (human)
peptide hormone bindingGalanin receptor type 2Homo sapiens (human)
neuropeptide bindingGalanin receptor type 2Homo sapiens (human)
galanin receptor activityGalanin receptor type 3Homo sapiens (human)
peptide hormone bindingGalanin receptor type 3Homo sapiens (human)
galanin receptor activityGalanin receptor type 1Homo sapiens (human)
protein bindingGalanin receptor type 1Homo sapiens (human)
peptide hormone bindingGalanin receptor type 1Homo sapiens (human)
neuropeptide bindingGalanin receptor type 1Homo sapiens (human)
G protein-coupled peptide receptor activityGalanin receptor type 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (5)

Processvia Protein(s)Taxonomy
plasma membraneGalanin receptor type 2Homo sapiens (human)
ciliumGalanin receptor type 2Homo sapiens (human)
membraneGalanin receptor type 2Homo sapiens (human)
plasma membraneGalanin receptor type 2Homo sapiens (human)
plasma membraneGalanin receptor type 3Homo sapiens (human)
ciliumGalanin receptor type 3Homo sapiens (human)
membraneGalanin receptor type 3Homo sapiens (human)
synapseGalanin receptor type 3Homo sapiens (human)
non-motile ciliumGalanin receptor type 3Homo sapiens (human)
plasma membraneGalanin receptor type 3Homo sapiens (human)
plasma membraneGalanin receptor type 1Homo sapiens (human)
membraneGalanin receptor type 1Homo sapiens (human)
plasma membraneGalanin receptor type 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID459286Binding affinity to human GalR12010Journal of medicinal chemistry, Feb-25, Volume: 53, Issue:4
Engineering galanin analogues that discriminate between GalR1 and GalR2 receptor subtypes and exhibit anticonvulsant activity following systemic delivery.
AID413941Binding affinity to human GalR22008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Design, synthesis, and characterization of high-affinity, systemically-active galanin analogues with potent anticonvulsant activities.
AID459287Binding affinity to human GalR22010Journal of medicinal chemistry, Feb-25, Volume: 53, Issue:4
Engineering galanin analogues that discriminate between GalR1 and GalR2 receptor subtypes and exhibit anticonvulsant activity following systemic delivery.
AID413940Binding affinity to human GalR12008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Design, synthesis, and characterization of high-affinity, systemically-active galanin analogues with potent anticonvulsant activities.
AID413942Binding affinity to human GalR32008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Design, synthesis, and characterization of high-affinity, systemically-active galanin analogues with potent anticonvulsant activities.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (47)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (2.13)18.7374
1990's14 (29.79)18.2507
2000's22 (46.81)29.6817
2010's10 (21.28)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 52.72

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index52.72 (24.57)
Research Supply Index3.93 (2.92)
Research Growth Index5.95 (4.65)
Search Engine Demand Index156.52 (26.88)
Search Engine Supply Index3.90 (0.95)

This Compound (52.72)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other50 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]